In August 2014, Safeguard Scientifics led New York City fintech company Transactis’ $11 million Series D.
Eighteen months later, the Radnor-based venture firm has again invested in the company, this time with five major U.S. banks, in a $30 million Series E. Safeguard’s co-investors are Capital One, Fifth Third, TD, PNC and Wells Fargo.
Safeguard CEO Stephen Zarrilli and partner Phil Moyer are both board members of the electronic billing company.
Safeguard Scientifics invested with 5 major banks in this $30M Series E
It’s Safeguard’s second time investing in New York City-based fintech company Transactis.
